Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study

BACKGROUND: Hepatocellular carcinoma (HCC) caused by hepatitis C virus (HCV) infection has become less and less due to the use of direct-acting antiviral agents (DAAs). Although it may be common to assume that eradication of the virus should improve the survival of HCC patients, large-scale randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yang, Zhang, Yue, Wang, Di, Shen, Di, Che, Yi-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345970/
https://www.ncbi.nlm.nih.gov/pubmed/32753950
http://dx.doi.org/10.2147/CMAR.S254580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345970/
https://www.ncbi.nlm.nih.gov/pubmed/32753950
http://dx.doi.org/10.2147/CMAR.S254580

Ejemplares similares